Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE005913 |
YEM_ID: | YEM-128 |
XU_ID: | XU-316 |
ID: | TCMBANKHE005913/YEM-128/XU-316 |
植物拉丁名: |
|
功能与主治: | To cool blood and stanch bleeding, quicken blood and transform stasis./Bleeding due to blood heat, amenorrhea due to blood stasis, knocks and falls, impediment pain in joints. |
药用植物名: | 茜草根|多花茜草|茜草 |
药名: | 茜草 |
来源: | 云南民族药物志：第一卷|甘肃省定西市岷县 |
药用部位: | root|全株 |
使用民族: | 阿昌族/白族/布依族/傣族/德昂族/回族/哈尼族/景颇族/拉祜族/傈僳族/苗族/纳西族/普米族/水族/彝族/藏族 |
KUMST_ID1: | KMUST-BS-0327 |
KUMST_ID2: | KMUST-202310210046-1，-2，-3 |
TCM_ID_id: | 3023 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000197 | 6-methoxyginiposidicacid | C17H24O11 | |||
| TCMBANKIN001606 | 2-Methyl-1,3,6-trihydroxy-9,10-anthraqui-none-3-O-beta-D-xylosyl-(1-->2)-beta-D-(6'-O-acetyl) glucoside | acetic acid [(2R,3S,4S,5R,6S)-6-[(4,7-dihydroxy-9,10-diketo-3-methyl-2-anthryl)oxy]-3,4-dihydroxy-5-[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]methyl ester; acetic acid [(2R,3S,4S,5R,6S)-6-[(4,7-dihydroxy-3-methyl-9,10-dioxo-2-anthryl)oxy]-3,4-dihydroxy-5-[[(2S,3R,4S,5R)-3,4,5-trihydroxy-2-tetrahydropyranyl]oxy]-2-tetrahydropyranyl]methyl ester; [(2R,3S,4S,5R,6S)-6-(4,7-dihydroxy-3-methyl-9,10-dioxo-anthracen-2-yl)oxy-3,4-dihydroxy-5-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxy-oxan-2-yl]methyl ethanoate; [(2R,3S,4S,5R,6S)-6-(4,7-dihydroxy-3-methyl-9,10-dioxoanthracen-2-yl)oxy-3,4-dihydroxy-5-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyoxan-2-yl]methyl acetate; [(2R,3S,4S,5R,6S)-6-[(4,7-dihydroxy-3-methyl-9,10-dioxo-2-anthryl)oxy]-3,4-dihydroxy-5-[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]methyl acetate | 606.58 | ||
| TCMBANKIN001812 | alizarin | SPECTRUM210850; KBio2_006002; Mitsui Alizarine B; 1,2-Dihydroxyanthraquinone; 32612_RIEDEL; ZINC03860973; Alizerine NAC; Alizarine Paste 20 percent Bluish; 4857-81-2; C37H34ClN2NaO6S2; Alizarine 3B; Deep Crimson Madder 10821E; SODIUM 3-({[(1E,4E)-4-[(2-CHLOROPHENYL)(4-{ETHYL[(3-SULFONATOPHENYL)METHYL]AMINO}PHENYL)METHYLIDENE]CYCLOHEXA-2,5-DIEN-1-YLIDENE](ETHYL)AMMONIO}METHYL)BENZENESULFONATE; 05560_FLUKA; CI 58000; C.I. Pigment Red 83C; BRN 1914037; Alizarin Red; Alizarine paste 20% bluish; C.I. Mordant Red 11C; KBioGR_002050; 333174_SIAL; 122777_SIAL; AIDS-001373; AKOS015916657; C.I. Mordant Red 11; SPBio_000613; CHEBI:16866; Hystazarin; Certiqual Alizarine; 1,2-dihydroxyanthra-9,10-quinone; D and C Orange No. 15; NCGC00095227-03; Hydrogen [4-[(2-chlorophenyl)[4-[Ethyl(3-sulphonatobenzyl)amino]phenyl]methylene]cyclohexa-2,5-dien-1-ylidene](ethyl)(3-sulphonatobe nzyl)ammonium Na salt; Alizerine Red IPP; Spectrum2_000397; AI3-18244; KBio1_001360; ALIZARIN GREEN; NCGC00095227-01; 72-48-0; NCI60_041501; alizarin ; 1,2-Dihydroxy-9,10-anthracenedione; Turkey Red W; Spectrum5_000150; 1,2-Dihydroxy-anthraquinone; Alizarine Red B2; 1,2-Dihydroxyanthrachinon; Sanyo Carmine L2B; Brilliant Acid Green; BG01793641; Alizarina; 1328-02-5; B0791; Alizarine Red L; Alizarine Lake Red IPX; Dihydroxy-9,10-anthracenedione; Anthraquinone, 1,2-dihydroxy-; Deep Crimson Madder 10821; Pigment red 83; Turkey Red (VAN); Alizarin; 1,2-Anthraquinonediol; Mitsui Alizarine BS; Alizarine Lake Red 2P; Brilliant Milling Green; Certiqual Alizarine D; NCGC00095227-02; BSPBio_001704; Alizarine Red IP; Alizarine Red IPP; SpecPlus_000320; Alizarinprimeveroside; potassium 3-[({4-[(2-chlorophenyl)(4-{ethyl[(3-sulfonatophenyl)methyl]iminio}cyclohexa-2,5-dien-1-ylidene)methyl]phenyl}(ethyl)amino)methyl]benzenesulfonate; Mordant Red 11; Eljon Madder M; D And C Orange Number 15; Sanyo Carmine l2BT; SDCCGMLS-0066502.P001; KBio2_000866; AIDS001373; 9,10-Anthracenedione, 1,2-dihydroxy-; D and C Orange Number 15D; NSC7212; Alizarine indicator; C01474; InChI=1/C14H8O4/c15-10-6-5-9-11(14(10)18)13(17)8-4-2-1-3-7(8)12(9)16/h1-6,15,18; ALIZARINE; MolPort-005-938-495; Turkey Red; 84754-86-9; EINECS 200-782-5; 1,2-Dihydroxy-9,10-anthraquinone; Alizarin B; MFCD00050440; W-110000; 1,2-dihydroxyanthracene-9,10-dione; 4-08-00-03256 (Beilstein Handbook Reference); NSC 7212; KBioSS_000866; 1,2-Dihydroxyanthrachinon [Czech]; I14-51626; SBB006481; Alizarine B; CCRIS 3530; Spectrum_000386; Spectrum3_000262; C.I. Pigment Red 83; NEPTUNE GREEN SG; Alizarine L paste; C.I. 58000C; KBio2_003434; Alizarine Red; KBio3_001204; Acid green 9; Alizarine Red B; LN: L C666 BV IVJ EQ FQ1; AC-20177; CBDivE_014227; Alizarine Lake Red 3P; Spectrum4_001555; DivK1c_006416; C.I. 58000; Eljon madder; Alizarine NAC | C14H8O4 | 240.21 | C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3)O)O |
| TCMBANKIN001971 | rubia akanera-iii | C41H50N6O10 | |||
| TCMBANKIN003584 | rubixanthin | E161d; CHEBI:8907; LMPR01070281; SCHEMBL43266; 0PWJ89032Q; (all-E,3R)-rubixanthin; C08611; Rubixanthin; g-Caroten-3-ol; 3-Hydroxy-g-carotene; CI 75135; (3R)-beta-4-Caroten-3-ol; (1R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E,19E)-3,7,12,16,20,24; (1R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E,19E)-3,7,12,16,20,24-hexamethylpentacosa-1,3,5,7,9,11,13,15,17,19,23-undecaenyl]-3,5,5-trimethylcyclohex-3-en-1-ol; 3763-55-1; E 161d; (3R)-beta,psi-caroten-3-ol; beta-4-Caroten-3-ol, (3R)-; UNII-0PWJ89032Q; ZINC8221265; AC1NQYA3; b,y-Caroten-3-ol; Natural yellow 27 | C40H56O | 552.87 | CC1=C(C(CC(C1)O)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC=C(C)CCC=C(C)C)C)C |
| TCMBANKIN004774 | rubia akanera-xiv | C48H58N6O15 | |||
| TCMBANKIN009754 | rubia akanera-xvi | C48H60N6O16 | |||
| TCMBANKIN009876 | mupinensisone | C30H48O2 | 440.7 g/mol | CC1(C2CCC3(C(C2(CCC1=O)C)CC=C4C3(CCC5(C4CC(CC5)(C)CO)C)C)C)C | |
| TCMBANKIN010618 | rubia akanera-vi | C41H50N6O10 | |||
| TCMBANKIN011930 | 6-methoxygossypol | 6-Methoxy-gossypol; 7-(8-formyl-1,6,7-trihydroxy-3-methyl-5-propan-2-yl-naphthalen-2-yl)-2,8-dihydroxy-3-methoxy-6-methyl-4-propan-2-yl-naphthalene-1-carbaldehyde; 7-(8-formyl-1,7-dihydroxy-5-isopropyl-6-methoxy-3-methyl-2-naphthyl)-2,3,8-trihydroxy-4-isopropyl-6-methyl-naphthalene-1-carbaldehyde; CTK1H3638; (2,2'-Binaphthalene)-8,8'-dicarboxaldehyde, 1,1',6,7,7'-pentahydroxy-6'-methoxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-; 6-Methoxygossypol; (+)-6-Methoxygossypol; DTXSID90202672; AC1MJ3SN; 7-(8-formyl-1,7-dihydroxy-6-methoxy-3-methyl-5-propan-2-ylnaphthalen-2-yl)-2,3,8-trihydroxy-6-methyl-4-propan-2-ylnaphthalene-1-carbaldehyde; 54302-42-0 | C31H32O8 | 532.6 g/mol | CC1=CC2=C(C(=C(C(=C2C(C)C)O)O)C=O)C(=C1C3=C(C4=C(C=C3C)C(=C(C(=C4C=O)O)OC)C(C)C)O)O |
| TCMBANKIN013084 | 3β-acetoxyolean-12-en-28-oicacid | 3β-acetoxyolean-12-en-28-oic acid | C32H50O4 | ||
| TCMBANKIN014115 | oleanolicaldehyde acetate | C32H50O3 | |||
| TCMBANKIN014415 | rubia akanera-x | C43H52N6O11 | |||
| TCMBANKIN014981 | 2-methoxy-naphthalene | C11H10O | 158.2 g/mol | COC1=CC2=CC=CC=C2C=C1 | |
| TCMBANKIN015160 | pseudoreserpine 16,17-stereoisomer | C32H38N2O9 | 0 | CC(=O)OC1C2CC3C4=C(CCN3CC2CC(C1O)OC(=O)C5=CC(=C(C(=C5)OC)OC)OC)C6=C(N4)C=C(C=C6)OC | |
| TCMBANKIN015841 | 4-hydroxy-2-[(e)-4-hydroxy-3-methyl-2-butenyl]-5-methylphenylβ-d-glucopyranoside | C18H26O8 | |||
| TCMBANKIN016743 | rubia akanera-xii | C46H58N6O14 | |||
| TCMBANKIN017638 | rubia akanera-viii | C42H52N6O10 | |||
| TCMBANKIN019406 | rubia akanera-xv | C48H60N6O15 | |||
| TCMBANKIN020177 | rubia akanera-ii | C40H48N6O9 | |||
| TCMBANKIN021504 | rubia akanera-v | C40H48N6O9 | |||
| TCMBANKIN022260 | rubia akanera-iv | C41H50N6O10 | CC1C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)N(C2C(C3=CC=C(C=C3)OC4=C(C=CC(=C4)CC(C(=O)N1)N(C2=O)C)OC)O)C)C)CC5=CC=C(C=C5)OC)C)C | ||
| TCMBANKIN022598 | mollugogenol a | C30H52O4 | 476.7 g/mol | CC1(C(CCC2(C1C(CC3(C2CCC4C3(CC(C5C4(CCC5C(C)(C)O)C)O)C)C)O)C)O)C | |
| TCMBANKIN023632 | 3'-Methoxyglabridin | AC1NSY37; 3'-methoxyglabridin; 4-(8,8-dimethyl-3,4-dihydro-2H-pyrano[2,3-f]chromen-3-yl)-2-methoxybenzene-1,3-diol; SCHEMBL10730635; LMPK12080018 | C21H22O5 | 354.4 g/mol | CC1(C=CC2=C(O1)C=CC3=C2OCC(C3)C4=C(C(=C(C=C4)O)OC)O)C |
| TCMBANKIN024138 | Nordamnacanthal | 2-Anthracenecarboxaldehyde, 9,10-dihydro-1,3-dihydroxy-9,10-dioxo-; AIDS098139; AIDS-098139; 1,3-dihydroxy-9,10-dioxo-anthracene-2-carbaldehyde; nordamnacanthal; 1,3-dihydroxy-9,10-dioxo-2-anthracenecarboxaldehyde; nordamnacanthal ; 1,3-dihydroxy-9,10-diketo-anthracene-2-carbaldehyde; CCRIS 6442; 3736-59-2; 1,3-dihydroxy-9,10-dioxoanthracene-2-carbaldehyde | C15H8O5 | 268.22 | C1=CC=C2C(=C1)C(=O)C3=CC(=C(C(=C3C2=O)O)C=O)O |
| TCMBANKIN024450 | rubia akanera-vii | C41H50N6O9 | |||
| TCMBANKIN025429 | 1'-Methoxy-2'-hydroxydihydromollugin | methyl 3,6-dihydroxy-4-methoxy-2,2-dimethyl-3,4-dihydrobenzo[h]chromene-5-carboxylate; AC1NSY3P; 1'-methoxy-2'-hydroxydihydromollugin | C18H20O6 | 332.38 | CC1(C(C(C2=C(O1)C3=CC=CC=C3C(=C2C(=O)OC)O)OC)O)C |
| TCMBANKIN025612 | rubia akanera-xiii | C48H60N6O16 | |||
| TCMBANKIN027943 | 16-carboxytotarol | C20H28O3 | CC(C)C1=C(C=CC2=C1CCC3C2(CCCC3(C)C(=O)O)C)O | ||
| TCMBANKIN031851 | 2-Methyl-1,3-cyclopentadione | 2-Methyl-1,3-cyclopentanedione; 117021_ALDRICH; 66515_FLUKA; ghl.PD_Mitscher_leg0.841; 765-69-5; 2-methylcyclopentane-1,3-quinone; AC-907/25014141; 2-Methylcyclopentane-1,3-dione; NSC54458; 1,3-Cyclopentanedione, 2-methyl-; EINECS 212-153-2 | C6H8O2 | 112.13 | CC1C(=O)CCC1=O |
| TCMBANKIN032205 | 6-methoxy-2-[2-(3-methoxyphenyl)ethyl]chromone | 6-methoxy-2-[2-(3-methoxyphenyl)ethyl]chromen-4-one; 6-methoxy-2-[2-(3-methoxyphenyl)ethyl]-4-chromenone; 6-Methoxy-2-[2-(3'-methoxyphenyl) ethyl] chromone | C19H18O4 | 310.3 g/mol | COC1=CC2=C(C=C1)OC(=CC2=O)CCC3=CC(=CC=C3)OC |
| TCMBANKIN032405 | rubia akanera-ix | C43H50N6O10 | |||
| TCMBANKIN035907 | 1,2,4-trihydroxynaphthalene-4-glucoside | C16H18O8 | C1=CC=C2C(=C1)C(=CC(=C2O)O)OC3C(C(C(C(O3)CO)O)O)O | ||
| TCMBANKIN036703 | 1,3,6-trihydroxy-2-methylanthraquinone-3-o-α-rhamnosyl(1→2)-3'-o-acetylglucoside | C29H32O15 | CC1C(C(C(C(O1)OC2C(C(C(OC2OC3=C(C(=C4C(=C3)C(=O)C5=C(C4=O)C=CC(=C5)O)O)C)CO)O)OC(=O)C)O)O)O | ||
| TCMBANKIN039594 | rubilactone | Rubilactone; 3'-Carbomethoxy-4'-hydroxynaphtho(1',2'-2,3)pyran-6-one; methyl 6-hydroxy-2-oxo-benzo[h]chromene-5-carboxylate; 6-hydroxy-2-oxo-5-benzo[h]chromenecarboxylic acid methyl ester; 6-hydroxy-2-keto-benzo[h]chromene-5-carboxylic acid methyl ester; DTXSID80161966; CHEMBL502634; 2H-Naphtho(1,2-b)pyran-5-carboxylic acid, 6-hydroxy-2-oxo-, methyl ester; 142182-54-5; methyl 6-hydroxy-2-oxobenzo[h]chromene-5-carboxylate; SCHEMBL16453602; AC1L30XS | C15H10O5 | 270.237 | c1([H])c([H])c(c(O[H])c(C(OC([H])([H])[H])=O)c(C([H])=C([H])C(=O)O2)c23)c3c([H])c1[H] |
| TCMBANKIN041764 | 2-methyl-3-(2',3',4'-trihydroxy-butyl)pyrazine | 2-methyl-3-(2',3',4'-trihydroxybutyl)pyrazine | C9H14N2O3 | 198.219 | |
| TCMBANKIN042055 | munjistin | C15H8O6 | 284.22 g/mol | C1=CC=C2C(=C1)C(=O)C3=CC(=C(C(=C3C2=O)O)C(=O)O)O | |
| TCMBANKIN043963 | Xanthopurpurin-3-O-β-D-glucoside | ||||
| TCMBANKIN044570 | rubiarbonol d | C32H52O5 | 516.8 g/mol | CC(C)C1CC(C2C1(CCC3(C2(CC=C4C3C(CC5C4(CC(C(C5(C)C)OC(=O)C)O)C)O)C)C)C)O | |
| TCMBANKIN045232 | 2-Carboxymethyl-3-prenyl-2,3-epoxy-1,4-naphthoquinone | 2-carboxymethyl-3-prenyl-2,3-epoxy-1,4-naphthoquinone | C17H16O5 | 300.33 | |
| TCMBANKIN045591 | 1-Hydroxy-2-methyl-6-methoxyanthraquinone | 268.28 | |||
| TCMBANKIN046237 | rubiprasin a | C32H52O5 | 516.75 | CC(=O)OC1CCC2(C(C1(C)C)CCC3(C2CC(=O)C4(C3(C(CC5(C4CC(CC5)(C)C)C)O)C)O)C)C | |
| TCMBANKIN046854 | pseudopurpurin | Pseudopurpurin; 2-Anthracenecarboxylic acid, 9,10-dihydro-1,3,4-trihydroxy-9,10-dioxo-; Pseudopurpurine; 2-Anthracenecarboxylicacid,9,10-dihydro-1,3,4-trihydroxy-9,10-dioxo-; SCHEMBL5075855; CTK1D7829; AC1L9DDH; 1,3,4-trihydroxy-9,10-dioxoanthracene-2-carboxylic acid; C10394; CHEBI:8608; AKOS028111424; 1,3,4-trihydroxy-9,10-dioxo-anthracene-2-carboxylic acid; DTXSID30197210; 476-41-5 | C15H8O7 | 300.22 | c1([H])c([H])c([H])c(C(=O)c(c(O[H])c(O[H])c(C(O[H])=O)c2O[H])c2C3=O)c3c1[H] |
| TCMBANKIN046913 | rubioncolin B | rubioncolin b | C31H24O10 | 556.5 g/mol | CC1(C23C(C4=C(C5=CC=CC=C5C(=C4C(=O)OC)O)OC2C6=C(O3)C7=CC=CC=C7C(=C6C(=O)OC)O)C(=O)O1)C |
| TCMBANKIN047895 | 11-Methoxynoryangonin | 11-methoxy-nor-yangonin | 274.27 g/mol | ||
| TCMBANKIN047928 | 4'-methoxy-5-hydroxy-8-3,3-dimethyl-allylflavone-3-rhamnosyl-(1-2)rhamnoside-7-glucoside | C39H50O18 | |||
| TCMBANKIN049378 | 1,3,6-Trihydroxy-2-methyl-9,10-anthra-quinone-3-O-(6'-O-acetyl)-beta-D-glucoside | 1,3,6-trihydroxy-2-methyl-9,10-anthra-quinone-3-o-(6'-o-acetyl)-β-d-glucoside | C23H22O11 | 474.414 | c12c(C(=O)c(c(O[H])c(C([H])([H])[H])c(O[C@]3([H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@@]([H])(C([H])([H])OC(=O)C([H])([H])[H])O3)c4[H])c4C1=O)c([H])c([H])c(O[H])c2[H] |
| TCMBANKIN049947 | 1-hydroxy-2-carboxy-3-methoxyanthraquinone | C16H10O6 | 298.25 g/mol | COC1=C(C(=C2C(=C1)C(=O)C3=CC=CC=C3C2=O)O)C(=O)O | |
| TCMBANKIN050016 | rubiatriol | A'-Neo-26,28-dinorgammacer-9(11)-ene-3,7,19-triol, 13,17-dimethyl-, (3beta,7alpha,8alpha,13alpha,14beta,17alpha,18beta,19alpha)-; 107694-02-0; (1R,3R,3aR,5aR,5bR,7aR,9S,11aS,13aS,13bR)-3a,5a,8,8,11a,13a-hexamethyl-3-propan-2-yl-1,2,3,4,5,5b,6,7,7a,9,10,11,13,13b-tetradecahydrocyclopenta[a]chrysene-1,9-diol; D:C-Friedo-B':A'-neogammacer-9(11)-ene-3,7,19-triol, (3beta,7alpha,19alpha)-; Rubiatriol; AC1L4DRZ | C30H50O3 | 458.72 | CC(C)C1CC(C2C1(CCC3(C2(CC=C4C3C(CC5C4(CCC(C5(C)C)O)C)O)C)C)C)O |
| TCMBANKIN058382 | 1-hydroxy-2-hydroxymethylanthraquinone | BRN 2218948; 9,10-Anthracenedione, 1-hydroxy-2-(hydroxymethyl)-; 1-Hydroxy-2-hydroxymethylanthraquinone; 1-Hydroxy-2-(hydroxymethyl)-9,10-anthracenedione; 9,10-Anthracenedione, 1-hydroxy-2-(hydroxymethyl)- (9CI); Digiferrugineol; 1-hydroxy-2-(hydroxymethyl)anthracene-9,10-dione; ANTHRAQUINONE, 1-HYDROXY-2-HYDROXYMETHYL-; 1-hydroxy-2-methylol-9,10-anthraquinone; C10327; 4-08-00-03278 (Beilstein Handbook Reference); Digiferruginol; 24094-45-9;1-Hydroxy-2-hydroxymethylanthraquinone; MolPort-039-338-647; 24094-45-9; Deoxylucidin; CHEBI:4544; BG00960207; CHEMBL495276; BRN 2218948; 1-Hydroxy-2-(hydroxymethyl)-9,10-anthracenedione; 1-hydroxy-2-(hydroxymethyl)anthracene-9,10-dione; ANTHRAQUINONE, 1-HYDROXY-2-HYDROXYMETHYL-; C10327; ACM24094459; 9,10-Anthracenedione, 1-hydroxy-2-(hydroxymethyl)- (9CI); 1-Hydroxy-2-(hydroxymethyl)anthra-9,10-quinone #; AC1L1N7Z; DTXSID40178818; 9,10-Anthracenedione, 1-hydroxy-2-(hydroxymethyl)-; Digiferrugineol; ZINC4098663; 4-08-00-03278 (Beilstein Handbook Reference); Digiferruginol; LS-20690; JCZCSQSSSAHDCB-UHFFFAOYSA-N;Deoxylucidin;digiferrugineol | C15H10O4 | 254.24 | C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3)CO)O |
| TCMBANKIN058383 | rubia akanera-i | alizarin;SPECTRUM210850; KBio2_006002; Mitsui Alizarine B; 1,2-Dihydroxyanthraquinone; 32612_RIEDEL; ZINC03860973; Alizerine NAC; Alizarine Paste 20 percent Bluish; 4857-81-2; C37H34ClN2NaO6S2; Alizarine 3B; Deep Crimson Madder 10821E; SODIUM 3-({[(1E,4E)-4-[(2-CHLOROPHENYL)(4-{ETHYL[(3-SULFONATOPHENYL)METHYL]AMINO}PHENYL)METHYLIDENE]CYCLOHEXA-2,5-DIEN-1-YLIDENE](ETHYL)AMMONIO}METHYL)BENZENESULFONATE; 05560_FLUKA; CI 58000; C.I. Pigment Red 83C; BRN 1914037; Alizarin Red; Alizarine paste 20% bluish; C.I. Mordant Red 11C; KBioGR_002050; 333174_SIAL; 122777_SIAL; AIDS-001373; AKOS015916657; C.I. Mordant Red 11; SPBio_000613; CHEBI:16866; Hystazarin; Certiqual Alizarine; 1,2-dihydroxyanthra-9,10-quinone; D and C Orange No. 15; NCGC00095227-03; Hydrogen [4-[(2-chlorophenyl)[4-[Ethyl(3-sulphonatobenzyl)amino]phenyl]methylene]cyclohexa-2,5-dien-1-ylidene](ethyl)(3-sulphonatobe nzyl)ammonium Na salt; Alizerine Red IPP; Spectrum2_000397; AI3-18244; KBio1_001360; ALIZARIN GREEN; NCGC00095227-01; 72-48-0; NCI60_041501; alizarin ; 1,2-Dihydroxy-9,10-anthracenedione; Turkey Red W; Spectrum5_000150; 1,2-Dihydroxy-anthraquinone; Alizarine Red B2; 1,2-Dihydroxyanthrachinon; Sanyo Carmine L2B; Brilliant Acid Green; BG01793641; Alizarina; 1328-02-5; B0791; Alizarine Red L; Alizarine Lake Red IPX; Dihydroxy-9,10-anthracenedione; Anthraquinone, 1,2-dihydroxy-; Deep Crimson Madder 10821; Pigment red 83; Turkey Red (VAN); Alizarin; 1,2-Anthraquinonediol; Mitsui Alizarine BS; Alizarine Lake Red 2P; Brilliant Milling Green; Certiqual Alizarine D; NCGC00095227-02; BSPBio_001704; Alizarine Red IP; Alizarine Red IPP; SpecPlus_000320; Alizarinprimeveroside; potassium 3-[({4-[(2-chlorophenyl)(4-{ethyl[(3-sulfonatophenyl)methyl]iminio}cyclohexa-2,5-dien-1-ylidene)methyl]phenyl}(ethyl)amino)methyl]benzenesulfonate; Mordant Red 11; Eljon Madder M; D And C Orange Number 15; Sanyo Carmine l2BT; SDCCGMLS-0066502.P001; KBio2_000866; AIDS001373; 9,10-Anthracenedione, 1,2-dihydroxy-; D and C Orange Number 15D; NSC7212; Alizarine indicator; C01474; InChI=1/C14H8O4/c15-10-6-5-9-11(14(10)18)13(17)8-4-2-1-3-7(8)12(9)16/h1-6,15,18; ALIZARINE; MolPort-005-938-495; Turkey Red; 84754-86-9; EINECS 200-782-5; 1,2-Dihydroxy-9,10-anthraquinone; Alizarin B; MFCD00050440; W-110000; 1,2-dihydroxyanthracene-9,10-dione; 4-08-00-03256 (Beilstein Handbook Reference); NSC 7212; KBioSS_000866; 1,2-Dihydroxyanthrachinon [Czech]; I14-51626; SBB006481; Alizarine B; CCRIS 3530; Spectrum_000386; Spectrum3_000262; C.I. Pigment Red 83; NEPTUNE GREEN SG; Alizarine L paste; C.I. 58000C; KBio2_003434; Alizarine Red; KBio3_001204; Acid green 9; Alizarine Red B; LN: L C666 BV IVJ EQ FQ1; AC-20177; CBDivE_014227; Alizarine Lake Red 3P; Spectrum4_001555; DivK1c_006416; C.I. 58000; Eljon madder; Alizarine NAC | C14H8O4 | 240.21 | C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3)O)O |
| TCMBANKIN058384 | purpurin | 81-54-9; EU-0000318; AIDS-001387; C.I. Natural Red 16; SDCCGMLS-0066870.P001; Smoke Brown G; 1,2,4-trihydroxyanthra-9,10-quinone; 229148_SIAL; NCGC00095346-02; NSC 10447; CCRIS 3527; Hydroxylizaric acid; 1,2,4-trihydroxyanthracene-9,10-dione; 1,2,4-Trihydroxyanthraquinone; InChI=1/C14H8O5/c15-8-5-9(16)14(19)11-10(8)12(17)6-3-1-2-4-7(6)13(11)18/h1-5,15-16,19; Purpurin; NCIMech_000036; SBB006444; C10395; SPBio_000133; 9,10-Anthracenedione, 1,2,4-trihydroxy-; C.I. 75410; Purpurine; C.I. Natural Red 8; ZINC03861633; CHEBI:8645; Spectrum3_001947; 9,10-Anthracenedione, 1,2,4-trihydroxy- (9CI); 82631_FLUKA; C.I. 1037; 1,2,4-Trihydroxyanthrachinon [Czech]; Anthraquinone, 1,2,4-trihydroxy-; Spectrum2_000037; BSPBio_003547; EINECS 201-359-8; 4-08-00-03568 (Beilstein Handbook Reference); NCGC00095346-01; NSC10447; AIDS001387; KBio3_002835; SPECTRUM1505300; NCI60_000107; 1,2,4-Trihydroxyanthrachinon; 1,2,4-Trihydroxy-9,10-anthraquinone; 1,2,4-Trihydroxy-9,10-anthracenedione; BRN 1887127; C.I. 58205; WLN: L C666 BV IVJ DQ EQ GQ | C14H8O5 | 256.21 g/mol | C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3O)O)O |
| TCMBANKIN058385 | purpuroxanthin | purpuroxan-thin;xanthopurpurin | C14H8O4 | 240.21 g/mol | C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=CC(=C3)O)O |
| TCMBANKIN059729 | 2-Methyl-1,3,6-trihydroxyanthraquinone | C15H10O5 | 270.24 g/mol | CC1=C(C=C2C(=C1O)C(=O)C3=C(C2=O)C=C(C=C3)O)O | |
| TCMBANKIN059942 | Tectochinon | C15H10O2 | 222.24 g/mol | CC1=CC2=C(C=C1)C(=O)C3=CC=CC=C3C2=O | |
| TCMBANKIN060142 | rubia akanera-xi | C42H50N6O11 | 814.88 | CC1C(=O)NC(C(=O)N(C(C(=O)NC(C(=O)N(C2CC3=CC=C(C=C3)OC4=C(C=CC(=C4)CC(C(=O)N1)N(C2=O)C)O)C)C)CC5=CC=C(C=C5)OC)C)CCC(=O)O | |
| TCMBANKIN060304 | regelin | C31H48O4 | 484.7 g/mol | CC1C(CC(C2(C1C3=CCC4C5(CCC(=O)C(C5CCC4(C3(CC2)C)C)(C)C)C)C)O)C(=O)OC | |
| TCMBANKIN061654 | alizarin 2-methylether | 1-hydroxy-2-methoxyanthracene-9,10-dione; Anthraquinone, 1-hydroxy-2-methoxy-; 6003-11-8; alizarin-2-methylether; 1-hydroxy-2-methoxy-9,10-anthraquinone; CCRIS 6434; C10291; MLS001049042; STOCK1N-33834; Alizarin 2-methyl ether; ZINC04042240; 9,10-Anthracenedione, 1-hydroxy-2-methoxy-; SMR000387052; 1-Hydroxy-2-methoxyanthraquinone; 1-hydroxy-2-methoxy-anthracene-9,10-dione;1-hydroxy-2-methoxyanthraquinone; Alizarin-2-methylether | C15H10O4 | 254.24 g/mol | COC1=C(C2=C(C=C1)C(=O)C3=CC=CC=C3C2=O)O |
| TCMBANKIN061688 | 2-methyl-1,3,6-trihydroxy-9,10-anthraquinone-3-o-β-d-xylosyl-(1→2)-β-d-(6'-o-acetyl)glucoside | C28H30O15 | COC1=C2C(=CC(=C1C(=O)OC)OC3C(C(C(C(O3)COC4C(C(C(CO4)O)O)O)O)O)O)C(=O)C5=CC=CC=C5C2=O | ||
| TCMBANKIN061929 | 1-methoxy-2-methoxymethyl-3-hydroxy-anthraquinone | C17H14O5 | COCC1=C(C=C2C(=C1OC)C(=O)C3=CC=CC=C3C2=O)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab